PATENT CLAIM ANALYSIS

Application Number: 15879999
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The present application is concerned with heterocyclic compounds that inhibit the activity of Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancers and other diseases.

Claim (Index 38):
A method of treating atherosclerosis comprising administering to a patient in need thereof a therapeutically effective amount of a compound of  claim 32  or a pharmaceutically acceptable salt or a stereoisomer thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.34483
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14465910', '15001826', '14155134', '14798137', '15166380']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.81091315915003
- 35 USC 102 Novelty (BERT): 0.5436355460888902
- Combined Prediction Score: 0.784185397843916
- Mean Citation Score: 403.687508
- Max Citation Score: 408.53394
- Similarity Product: 308.1252267084968

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test